|
|
| MRD / Regn No. |
: SG001178 |
Date |
: 08/06/2026 |
| Patient Name |
: SK.Abul Kalam Azad |
Age & Gender |
: 62 Yrs. / Male |
| Contact No. |
: 8927779268 |
UHID |
: |
| Ht / Wt / BMI |
: 156 / 66 / 27.12 |
BP S / BP D |
: 128 / 91 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
HYPOTHYROIDISM (25/May/2023) | HYPERTENSION (25/May/2023) | TYPE 2 DIABETES (25/May/2021) | |
| Salient Investigations |
: |
HBA1C GLYCOSYLATED HEMOGLOBIN: 9.6 % | MICROALBUMIN CREATININE RATIO: 14.19 mcg/mg |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
THYROXINE 50 MCG THYRONORM 50 MCG |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
| MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR BREAKFAST MUST BE TAKEN ONLY AFTER 30 MINUTES. OTHER DRUGS CAN INTERFERE WITH THE ABSORPTION OF THYROXINE | |
|
2 |
TABLET ROSUVASTATIN 20 MG STATEZE R 20 |
PO |
0-0-1 |
BEFORE DINNER
|
|
|
|
3 |
AMLODIPINE 5 MG + TELMISARTAN 40 MG TAZLOC AM |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
4 |
ANTIHYPERGLYCEMIC SITAGLIPTIN 100 MG + DAPAGLIFLOZIN 10 MG + METFORMIN 1000 MG LUPISIT DM 1000 |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
5 |
INJECTION GLARGINE (INJ U100) BASALOG Medicine For GLUCOSE CONTROL |
SQ |
0-0-40 |
BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE LOW BLOOD SUGAR | |
|
6 |
INJECTION FAST ASPART (INJ U100) FIASP Medicine For T1DM, T2DM |
SQ |
0-28-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
7 |
TABLET ACARBOSE 50 MG GLUCOBAY 50 MG Medicine For DIABETES |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 08/Dec/2026 |
| Tests Suggested For Next Visit |
: SMBG,HBA1C-HPLC METHOD,UACR:SPOT SAMPLE |
| |
|
| |
|
 Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal /
54020
This is a Computer generated Prescription |
Powered By:  |